We focused on the survival of PC-9 cells exposed to gefitinib for the first time.
We found extracellular FGF2 could confer survival to the cells exposed to gefitinib.
FGF2 may be supplied from neighboring cells killed by gefitinib.
Altruistic survival based on neighbors' death may occur in gefitinib-treated cells.